Skip to main content

Table 8 Comparing metabolic profile, vitamin D level and fibroscan changes after vitamin D supplementation between both groups

From: Stoss therapy versus weekly regimen of vitamin D in children with chronic liver disease: a randomized pilot study

Change

Group A

Group B

Test value‡

p-value

Sig

No. = 12

No. = 12

S. Ca (mg/dl)

Mean ± SD

0.75 ± 0.62

0.83 ± 0.89

 − 0.029

0.977

NS

Range

 − 0.6–1.7

 − 0.6–2.3

S. Po4 (mg/dl)

Mean ± SD

0.32 ± 1.02

0.13 ± 0.63

 − 0.491

0.623

NS

Range

 − 1.5–2.5

 − 0.9–1

S. ALP (U/l)

Mean ± SD

 − 82.75 ± 46.06

 − 90.50 ± 87.48

 − 0.375

0.707

NS

Range

 − 162 to − 9

 − 217–33

Vitamin D (ng/ml)

Mean ± SD

17.33 ± 4.60

17.42 ± 3.55

 − 0.145

0.885

NS

Range

9–25

10–22

Fibroscan

Mean ± SD

0.21 ± 2.00

0.27 ± 2.03

 − 0.289

0.772

NS

Range

 − 1.9–6

 − 3–5.9

  1. ‡Mann Whitnet test